Oral Peptide Delivery in 2026: How Icotrokinra's FDA Approval Rewrites the Rules
The first oral targeted peptide approved for psoriasis signals a new era. Here is what the science of oral peptide delivery means for integrative medicine.
Peptide Therapy
Oral Peptide Delivery in 2026: How Icotrokinra's FDA Approval Rewrites the Rules. Part of the Peptide Therapy library by Dr. med. univ. Julian Douwes